VGK vs XLV
Vanguard FTSE Europe ETF vs Health Care Select Sector SPDR Fund
- • VGK has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • VGK pays a higher dividend yield (2.90%).
Side-by-side metrics
| Metric | VGK | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 2.90% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $37.86B | $40.60B |
YTD return | 7.41% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.90 | 0.51 |
P/E ratio | 17.85 | 29.12 |
Last price | $88.66 | $161.81 |
Inception | — | — |
Issuer | Vanguard | State Street |
VGK top holdings
| ASML.AS | ASML Holding NV | 3.97% |
| HSBA.L | HSBC Holdings PLC | 2.04% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.87% |
| NOVN.SW | Novartis AG Registered Shares | 1.83% |
| AZN.L | AstraZeneca PLC | 1.76% |
| NESN.SW | Nestle SA | 1.65% |
| SHEL.L | Shell PLC | 1.52% |
| SIE.DE | Siemens AG | 1.46% |
| SAP.DE | SAP SE | 1.18% |
| SAN.MC | Banco Santander SA | 1.16% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About VGK
VGK (Vanguard FTSE Europe ETF) is European developed-market equities. Managed by Vanguard, the fund carries $37.9B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.90%. Its largest holding is ASML Holding NV (ASML.AS), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.